Buffett's Berkshire invests in four big drugmakers
Add BT as a preferred source
[BENGALURU] Warren Buffett's Berkshire Hathaway said on Monday it has begun investing in the stocks of four large drugmakers.
In a regulatory filing detailing its US-listed investments as of Sept 30, Berkshire disclosed new stakes in Abbvie Inc, Bristol-Myers Squibb and Merck & Co of more than US$1.8 billion each, and a new US$136 million stake in Pfizer Inc.
Investors monitor Omaha, Nebraska-based Berkshire's quarterly filings to see where Mr Buffett and his portfolio managers Todd Combs and Ted Weschler see value.
Shares of the four drugmakers rose in after-hours trading, which often occurs when Berkshire discloses new investments, reflecting what investors view as Mr Buffett's imprimatur.
Berkshire did not say whether Mr Buffett made the investments, though larger investments are normally his.
The investments look similar to the multi-billion dollar stakes that Berkshire recently maintained in the four largest US airlines, before selling them in April amidst the coronavirus pandemic.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
In Monday's filing, Berkshire also revealed a new US$276 million stake in wireless phone company T-Mobile US Inc.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
